A new screening method for pathway-specific antifungal compounds.
Morishita
Atsuki
A
Institute for Life Science Research, Asahi Kasei Pharma Corporation, 2-1, Samejima, Fuji-City, Shizuoka 416-8501, Japan. morishita.ad@om.asahi-kasei.co.jp
Muramatsu
Syuji
S
Fukuzaki
Kentarou
K
Ishikawa
Satoru
S
Matsuda
Akio
A
D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology*; D002176:Candida albicans / Q000187:drug effects*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D005285:Fermentation; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008826:Microbial Sensitivity Tests; D010088:Oxidoreductases / Q000378:metabolism; D051381:Rats; D012680:Sensitivity and Specificity; D058886:Sterol 14-Demethylase
D000935:Antifungal Agents; C548418:CYP51A1 protein, human; D003577:Cytochrome P-450 Enzyme System; D010088:Oxidoreductases; D058886:Sterol 14-Demethylase